MON-773 The Comparison Study of Bone Mineral Density(BMD) between Pateints with Normocalcemic and Hypercalcemic Hyperparathyroidism after Kidney Transplantation and its Predictors

Abstract Disclosure: G. Saksirisampant: None. Introduction: Persistent hyperparathyroidism is a well-established complication following kidney transplantation with a significant impact on bone health. This condition can lead to bone thinning and an elevated risk of fractures. However, a comparison between normocalcemic and hypercalcemic hyperparathyroidism is less well-studied. Objective: This study aims to compare bone mineral density (BMD) values among post-kidney transplant patients with normocalcemic hyperparathyroidism and hypercalcemic hyperparathyroidism. The secondary objective is to explore clinical factors that predict BMD values and BMD changes over time in this population. Method: This cross-sectional study included patients who were more than 1 year post-kidney transplant and had persistent hyperparathyroidism documented more than 2 times. Medical history, laboratory results and BMD values were collected. Results: This study included a total of 130 patients, 64 (49.2%) had normocalcemic hyperparathyroidism and 66 (50.8%) had hypercalcemic hyperparathyroidism. 53 patients underwent BMD measurement. There were no different in baseline characteristic between BMD measurement and non-BMD measurement group (excluding BMI and parental hip fracture). Patients in the hypercalcemic hyperparathyroidism group had higher iPTH levels (127.1 vs 84.6 pg/mL, P <0.001) and corrected calcium levels (10.7 vs 9.6 mg/dL, P < 0.001) when compared to those in the normocalcemic group. Mean BMD values (g/cm²) in the hypercalcemic vs normocalcemic groups at all sites were similar. Corrected calcium levels showed a non-significant trend to a negative association with BMD change (n = 17) at the femoral neck (β -0.026, P = 0.097) and a significant negative association with BMD change at the 1/3 radius (β -0.033, P = 0.033). Conclusion: Among persistent hyperparathyroidism after kidney transplant patients, BMD results of hypercalcemic and normocalcemic hyperparathyroidism were similar. High corrected calcium levels associated with more bone loss in cortical-dominated bone, particularly in the 1/3 radius. Presentation: Monday, July 14, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.515
Primary Topic
Bone and Joint Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MON-773 The Comparison Study of Bone Mineral Density(BMD) between Pateints with Normocalcemic and Hypercalcemic Hyperparathyroidism after Kidney Transplantation and its Predictors

Gasit Saksirisampant
Journal of the Endocrine Society
Bone and Joint Diseases
article

MON-773 The Comparison Study of Bone Mineral Density(BMD) between Pateints with Normocalcemic and Hypercalcemic Hyperparathyroidism after Kidney Transplantation and its Predictors

Gasit Saksirisampant
article en

Abstract

Abstract Disclosure: G. Saksirisampant: None. Introduction: Persistent hyperparathyroidism is a well-established complication following kidney transplantation with a significant impact on bone health. This condition can lead to bone thinning and an elevated risk of fractures. However, a comparison between normocalcemic and hypercalcemic hyperparathyroidism is less well-studied. Objective: This study aims to compare bone mineral density (BMD) values among post-kidney transplant patients with normocalcemic hyperparathyroidism and hypercalcemic hyperparathyroidism. The secondary objective is to explore clinical factors that predict BMD values and BMD changes over time in this population. Method: This cross-sectional study included patients who were more than 1 year post-kidney transplant and had persistent hyperparathyroidism documented more than 2 times. Medical history, laboratory results and BMD values were collected. Results: This study included a total of 130 patients, 64 (49.2%) had normocalcemic hyperparathyroidism and 66 (50.8%) had hypercalcemic hyperparathyroidism. 53 patients underwent BMD measurement. There were no different in baseline characteristic between BMD measurement and non-BMD measurement group (excluding BMI and parental hip fracture). Patients in the hypercalcemic hyperparathyroidism group had higher iPTH levels (127.1 vs 84.6 pg/mL, P <0.001) and corrected calcium levels (10.7 vs 9.6 mg/dL, P < 0.001) when compared to those in the normocalcemic group. Mean BMD values (g/cm²) in the hypercalcemic vs normocalcemic groups at all sites were similar. Corrected calcium levels showed a non-significant trend to a negative association with BMD change (n = 17) at the femoral neck (β -0.026, P = 0.097) and a significant negative association with BMD change at the 1/3 radius (β -0.033, P = 0.033). Conclusion: Among persistent hyperparathyroidism after kidney transplant patients, BMD results of hypercalcemic and normocalcemic hyperparathyroidism were similar. High corrected calcium levels associated with more bone loss in cortical-dominated bone, particularly in the 1/3 radius. Presentation: Monday, July 14, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Ramathibodi Hospital (TH)
Openalex Percentile: Top 61%
Bone and Joint Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.